Experimental Hematology
Volume 38, Issue 5 , Pages 341-350 , May 2010

Proteome of platelets in patients with coronary artery disease

  • Cristina Banfi

      Affiliations

    • Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy
    • Department of Pharmacological Sciences, University of Milan, Milan, Italy
    • Drs. Banfi and Brioschi contributed equally to this work.
    • Corresponding Author InformationOffprint requests to: Cristina Banfi, Ph.D., Centro Cardiologico Monzino, I.R.C.C.S., Via Parea 4, 20138 Milano, Italy
    • ,
  • Maura Brioschi

      Affiliations

    • Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy
    • Department of Pharmacological Sciences, University of Milan, Milan, Italy
    • Drs. Banfi and Brioschi contributed equally to this work.
    • ,
  • Giancarlo Marenzi

      Affiliations

    • Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy
    • Institute of Cardiology, University of Milan, Italy
    • ,
  • Monica De Metrio

      Affiliations

    • Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy
    • Institute of Cardiology, University of Milan, Italy
    • ,
  • Marina Camera

      Affiliations

    • Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy
    • Department of Pharmacological Sciences, University of Milan, Milan, Italy
    • ,
  • Luciana Mussoni

      Affiliations

    • Department of Pharmacological Sciences, University of Milan, Milan, Italy
    • ,
  • Elena Tremoli

      Affiliations

    • Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy
    • Department of Pharmacological Sciences, University of Milan, Milan, Italy

Received 6 October 2009 ,Revised 26 February 2010 ,Accepted 2 March 2010.

References 

  1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326:310–318
  2. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481–3488
  3. Gawaz M. The evolving science of atherothrombotic disease. Eur Heart J Suppl. 2008;10:I4–I7
  4. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–2494
  5. Blackstock WP, Weir MP. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999;17:121–127
  6. Watson SP, Bahou WF, Fitzgerald D, Ouwehand W, Rao AK, Leavitt AD. ISTH Platelet Physiology Subcommittee. Mapping the platelet proteome: a report of the ISTH Platelet 7. Physiology Subcommittee. J Thromb Haemost. 2005;3:2098–2101
  7. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood. 2003;101:2285–2293
  8. Howes JM, Keen JN, Findlay JB, Carter AM. The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease. Diab Vasc Dis Res. 2008;5:205–212
  9. Maurer-Spurej E, Kahr WH, Carter CJ, Pittendreigh C, Cameron M, Cyr TD. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets. 2008;19:342–351
  10. Springer DL, Miller JH, Spinelli SL, et al. platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res. 2009;8:2261–2272
  11. Marcus K, Moebius J, Meyer HE. Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets. Anal Bioanal Chem. 2003;376:973–993
  12. Brambilla M, Camera M, Colnago D, et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol. 2008;28:947–953
  13. Gelosa P, Banfi C, Brioschi M, et al. S 35171 exerts protective effects in spontaneously hypertensive stroke-prone rats by preserving mitochondrial function. Eur J Pharmacol. 2009;604:117–124
  14. Banfi C, Brioschi M, Barcella S, et al. Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme. Proteomics. 2009;9:1344–1352
  15. Heller M, Ye M, Michel PE, et al. Added value for tandem mass spectrometry shotgun proteomics data validation through isoelectric focusing of peptides. J Proteome Res. 2005;4:2273–2282
  16. Szutowicz A, Lysiak W, Angielski S. The effect of (-)hydroxycitrate on pyruvate metabolism in rat brain synaptosomes. J Neurochem. 1977;29:375–378
  17. Banfi C, Mussoni L, Risé P, et al. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type-1 in cultured HepG2 cells. Circ Res. 1999;85:208–217
  18. Tyers M, Rachubinski RA, Stewart MI, et al. Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature. 1988;333:470–473
  19. Zappacosta B, De Sole P. Lactic dehydrogenase activity of platelet subpopulations during pregnancy. Arch Gynecol Obstet. 1992;251:165–169
  20. Zoli A, Zappacosta B, Altomonte L, et al. Platelet lactate dehydrogenase activity in systemic lupus erythematosus: correlation with anticardiolipin antibodies. J Rheumatol. 1995;22:649–653
  21. Zappacosta B, De Sole P, Rossi C, Marra G, Ghirlanda G, Giardina B. Lactate dehydrogenase activity of platelets in diabetes mellitus. Eur J Clin Chem Clin Biochem. 1995;33:487–489
  22. Cesar JM, Pallares E, Rubí J, Navarro JL. Lactate production by thrombin-activated platelets of patients with primary thrombocytemia. Thromb Res. 2006;118:335–339
  23. Leoncini G, Maresca M, Armani U, Piana A. Lactate overproduction in platelets of subjects affected with myeloproliferative disorders. Scand J Haematol. 1985;35:229–332
  24. Michno A, Skibowska A, Raszeja-Specht A, Cwikowska J, Szutowicz A. The role of adenosine triphosphate citrate lyase in the metabolism of acetyl coenzyme a and function of blood platelets in diabetes mellitus. Metabolism. 2004;53:66–72
  25. Michno A, Raszeja-Specht A, Jankowska-Kulawy A, Pawelczyk T, Szutowicz A. Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons. Clin Chem. 2005;51:1673–1682
  26. Craik JD, Stewart M, Cheeseman CI. GLUT-3 (brain-type) glucose transporter polypeptides in human blood platelets. Thromb Res. 1995;79:461–469
  27. Landon F, Huc C, Thomé F, Oriol C, Olomucki A. Human platelet actin. Evidence of beta and gamma forms and similarity of properties with sarcomeric actin. Eur J Biochem. 1977;81:571–577
  28. Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci. 1998;111:713–722
  29. Cohen Z, Davis-Gorman G, McDonagh PF, Ritter L. Caspase inhibition of platelet activation. Blood Coagul Fibrinolysis. 2008;19:305–309
  30. Fox JE. Cytoskeletal proteins and platelet signaling. Thromb Haemost. 2001;86:198–213
  31. de Hostos EL, Bradtke B, Lottspeich F, Guggenheim R, Gerisch G. Coronin, an actin binding protein of Dictyostelium discoideum localized to cell surface projections, has sequence similarities to G protein beta subunits. EMBO J. 1991;10:4097–4104
  32. Uetrecht AC, Bear JE. Coronins: the return of the crown. Trends Cell Biol. 2006;16:421–426
  33. Humphries CL, Balcer HI, D'Agostino JL, et al. Direct regulation of Arp2/3 complex activity and function by the actin binding protein coronin. J Cell Biol. 2002;159:993–1004
  34. Cai L, Marshall TW, Uetrecht AC, Schafer DA, Bear JE. Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. Cell. 2007;128:915–929
  35. Li Z, Kim ES, Bearer EL. Arp2/3 complex is required for actin polymerization during platelet shape change. Blood. 2002;99:4466–4474
  36. Ostrowska H, Ostrowska JK, Worowski K, Radziwon P. Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28. A preliminary report. Platelets. 2003;14:151–157
  37. Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol. 2001;8:739–758
  38. Ma AD, Abrams CS. Pleckstrin homology domains and phospholipid-induced cytoskeletal reorganization. Thromb Haemost. 1999;82:399–406
  39. García A, Senis YA, Antrobus R, et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics. 2006;6:5332–5343
  40. Gabbeta J, Yang X, Sun L, McLane MA, Niewiarowski S, Rao AK. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. Blood. 1996;87:1368–1376

PII: S0301-472X(10)00078-0

doi: 10.1016/j.exphem.2010.03.001

Experimental Hematology
Volume 38, Issue 5 , Pages 341-350 , May 2010

Article Tools

* Image Usage & Resolution